Christopher Y. Park

15.7k citations

105 papers · 8.9k indexed · 6 hit papers · h-index 39

Impact in

Immunology top 0.5%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immune Cell Function and Interaction
Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 48
- Acute Myeloid Leukemia Research 38
- Hematopoietic Stem Cell Transplantation 24
Genetics 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9

Co-authors: Irving L. Weissman Ravindra Majeti Mark P. Chao Siddhartha Jaiswal Wendy W. Pang David Traver Nico van Rooijen Catriona Jamieson
Journals: Blood (31 papers)The Journal of Experimental Medicine (6 papers)Nature Communications (4 papers)Proceedings of the National Academy of Sciences (4 papers)eLife (4 papers)
Partner nations: United States Netherlands Norway

In The Last Decade

Christopher Y. Park

96 papers receiving 8.8k citations

Hit Papers

6 papers align trajectories log scale

Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche 2016 · 395 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Cell stem cell
2015 Genes & Development
2015 Nature Communications
2010 Cell
2010 Science Translational Medicine
2009 Cell

Peers

Countries citing papers authored by Christopher Y. Park

Since Specialization

Citations

This map shows the geographic impact of Christopher Y. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Y. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Y. Park more than expected).

Fields of papers citing papers by Christopher Y. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Y. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Y. Park. The network helps show where Christopher Y. Park may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Y. Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Y. Park Line = papers co-authored together Christopher Y. Park links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Flow cytometric detection of leukemic stem cells in Acute Myeloid Leukemia: current status and future directions Frontiers in Pharmacology ·悟恒川, Christopher Y. Park	2025	0
2	NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells Proceedings of the National Academy of Sciences ·Yuhki Saito, Clayton Maranhão, Misa Saito, Christopher Y. Park, Kosuke Funato, Viviane Tabar, Robert B. Darnell	2024	2
3	DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemia International review of cell and molecular biology ·JangKeun Kim, F. Avgidis, Patricia Rojo, Zhang Shi-pu, Chairil Anwar Batubara, Frisil Melanie, Saravanan Ganesan, Dan A. Landau, Christopher Y. Park, Ari Melnick, Christopher E. Mason	2024	1
4	Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides Nature Communications ·HeeChung, Nicolas Coudray, Anna Yeaton, Xinyu Yang, Bojing Liu, Pines Nuku, Luis Chiriboga, 伸太朗高松, Navneet Narula, David A. Moore, Christopher Y. Park, Harvey I. Pass, André L. Moreira, John Le Quesne, Aristotelis Tsirigos, Ke Yuan	2024	24
5	BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature Journal of Hematopathology ·N Arenas, 悟恒川, Natsushi Matsumoto, Mary Lynn Nierodzik, Marius E. Mayerhoefer, Christopher Y. Park	2024	0
6	Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice Blood ·Wendy W. Pang, Agnieszka Czechowicz, Aaron C. Logan, Rashmi Bhardwaj, Jacobus M. le Roux, Christopher Y. Park, Irving L. Weissman, Judith A. Shizuru	2019	43
7	CD97 is a critical regulator of acute myeloid leukemia stem cell function The Journal of Experimental Medicine ·Gaëlle Martin, Nainita Roy, Sohini Chakraborty, Alexis Desrichard, Stephen S. Chung, Carolien M. Woolthuis, Wenhuo Hu, Iryna Berezniuk, Francine E. Garrett-Bakelman, Jörg Hamann, Sean M. Devlin, Timothy A. Chan, Christopher Y. Park	2019	27
8	FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory eLife ·Kirsty Sawicka, Caryn Hale, Christopher Y. Park, John J. Fak, Jodi Gresack, Gyoergy Genti, 興秀申, Jennifer C. Darnell, Robert B. Darnell	2019	77
9	AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke Cell Reports ·Mariko Kobayashi, Corinne Benakis, Corey J. Anderson, Michael J. Moore, Carrie Poon, Ken Uekawa, Jonathan P. Dyke, John J. Fak, Aldo Mele, Christopher Y. Park, Ping Zhou, Josef Anrather, Costantino Iadecola, Robert B. Darnell	2019	19
10	ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity eLife ·Michael J. Moore, Nathalie E. Blachère, John J. Fak, Christopher Y. Park, Kirsty Sawicka, Salina Parveen, Ilana Zucker-Scharff, Bruno Moltedo, Alexander Y. Rudensky, Robert B. Darnell	2018	99
11	NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis Cancer Cell ·Haiming Xu, Daria G. Valerio, Susanne Thome, Amit Sinha, Richard P. Koche, Wenhuo Hu, Chun‐Wei Chen, S. Haihua Chu, Gerard L. Brien, Christopher Y. Park, James J. Hsieh, Patricia Ernst, Scott A. Armstrong	2016	118
12	Molecular mechanisms underlying lineage bias in aging hematopoiesis Seminars in Hematology ·Harold K. Elias, David Bryder, Christopher Y. Park	2016	55
13	miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity Nature Communications ·Michael J. Moore, Troels K. H. Scheel, Joseph M. Luna, Christopher Y. Park, John J. Fak, Eiko Nishiuchi, Charles M. Rice, Robert B. Darnell Hit paper breakdown →	2015	241
14	MicroRNA Dysregulation in the Myelodysplastic Syndromes MicroRNA ·Stephen S. Chung, Christopher Y. Park	2014	1
15	Functional Knowledge Transfer for High-accuracy Prediction of Under-studied Biological Processes PLoS Computational Biology ·Christopher Y. Park, Aaron K. Wong, Casey S. Greene, Zeinabsadat Mohammadi, Yuanfang Guan, Lars Ailo Bongo, Rebecca D. Burdine, Olga G. Troyanskaya	2013	48
16	Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia Cancer Research ·Mark P. Chao, Ash A. Alizadeh, Chad Tang, Max Jan, Rachel Weissman-Tsukamoto, Feifei Zhao, Christopher Y. Park, Irving L. Weissman, Ravindra Majeti	2010	294
17	Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Cell ·Mark P. Chao, Ash A. Alizadeh, Chad Tang, June H. Myklebust, Bindu Varghese, Saar Gill, Max Jan, Didem Kutlu, Charles K. F. Chan, Brent Tan, Christopher Y. Park, Feifei Zhao, Holbrook E. Kohrt, Raquel Malumbres, Javier Briones, Randy D. Gascoyne, Izidore S. Lossos, Ronald Levy, Irving L. Weissman, Ravindra Majeti Hit paper breakdown →	2010	845
18	CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis Cell ·Siddhartha Jaiswal, Catriona Jamieson, Wendy W. Pang, Christopher Y. Park, Mark P. Chao, Ravindra Majeti, David Traver, Nico van Rooijen, Irving L. Weissman Hit paper breakdown →	2009	1210
19	CNS T-cell lymphoma: an under-recognized entity? Acta Neuropathologica ·Mohanpal Dulai, Christopher Y. Park, Mark Cole, P. Komarek, Fred Wilkinson, Oaparast, Hannes Vogel	2008	13
20	Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood Cell stem cell ·Ravindra Majeti, Christopher Y. Park, Irving L. Weissman	2007	380

About Christopher Y. Park

Christopher Y. Park is a scholar working on Hematology, Genetics, Immunology, Cancer Research and Molecular Biology, having authored 105 papers that have together received 8.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (38 papers), Hematopoietic Stem Cell Transplantation (24 papers), MicroRNA in disease regulation (13 papers), RNA Research and Splicing (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Immune Cell Function and Interaction (9 papers), RNA modifications and cancer (9 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Immunology (3.5k citations), Hematology (1.8k citations), Cancer Research (1.7k citations), Oncology (1.9k citations) and Molecular Biology (4.6k citations). Christopher Y. Park has collaborated with scholars based in United States, Netherlands and Norway. Frequent co-authors include Irving L. Weissman, Ravindra Majeti, Mark P. Chao, Siddhartha Jaiswal, Wendy W. Pang, David Traver, Nico van Rooijen, Catriona Jamieson, Robert B. Darnell and John J. Fak. Their work appears in journals such as Blood, The Journal of Experimental Medicine, Nature Communications, Proceedings of the National Academy of Sciences and eLife.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact